05
12
2023
Medicilon stands out among many CROs in the country by virtue of advanced R&D technology, innovative service platform, outstanding performance and excellent market reputation, as a result, Medicilon is awarded the “Golden Horse Award - 2022 Best Preclinical CRO/CDMO Enterprise.”
05
09
2023
On March 24, 2023, Dr. Xingquan Ma, SVP of the Chemistry Department of Medicilon, gave a report titled "Medicinal Chemistry in Small Nucleic Acid Drugs Discovery" during the IDC2023 4th Chemical New Drug and Improved New Drug R&D Forum.
05
09
2023
Based on the technical basis of flow cytometry, the Medicilon flow sorting platform is widely used in scientific research and work in immunology, cell biology, oncology, hematology, drug development, and environmental testing.
04
26
2023
Medicilon Preclinical Research (Shanghai) LLC (MPR) has obtained the GLP (Good Laboratory Practice) certification of the National Medical Products Administration (NMPA) for the newly added facilities at Nanhui Park.
03
28
2023
On March 25, the Shanghai Industrial Technology Innovation Promotion Association, the City Association for Science and Technology and the Baoshan District Government released the "2023 Shanghai Hardcore Technology Enterprises TOP100 List".
